Quick Answer
Rallybio Corp reported Stockholders Equity of $57.96 million for fiscal year 2025.
Rallybio Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $57.96M | -6.0% |
| 2024 | $61.65M | -41.9% |
| 2023 | $106.18M | -37.3% |
| 2022 | $169.32M | -3.6% |
| 2021 | $175.60M | +29.1% |
| 2020 | $136.00M | +706.7% |
| 2019 | $16.86M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $63.03M | -11.0% | +37.1% |
| June 30, 2025 | $45.96M | -42.6% | -15.0% |
| March 31, 2025 | $54.07M | -39.4% | -12.3% |
| December 31, 2024 | $61.65M | -41.9% | -12.9% |
| September 30, 2024 | $70.82M | -42.7% | -11.5% |
| June 30, 2024 | $80.02M | -42.5% | -10.3% |
| March 31, 2024 | $89.16M | -42.6% | -16.0% |
| December 31, 2023 | $106.18M | -37.3% | -14.1% |
- Rallybio Corp showed a decrease of -6.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Rallybio Corp’s stockholders equity has grown by 243.7% (from $16.86 million to $57.96 million).
- The most recent figure is from Rallybio Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: